Publications

Featured Publications

Leveraging a deep bench of expertise and foundational experience in DNA medicine development, we’re driving research that has the potential to transform treatment paradigms and improve patients’ lives.

COVID-19

Title Disease Target Product
Immunogenicity of a DNA vaccine candidate for COVID-19
Nature Communications — May 2020
COVID-19 INO-4800
571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster
Open Forum Infectious Diseases — December 2021
COVID-19 INO-4800
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
The Journal of Infectious Diseases — January 2022
COVID-19 INO-4800
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
npj Vaccines — October 2021
COVID-19 INO-4800
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
Human Vaccines & Immunotherapeutics — November 2023
COVID-19 INO-4800